Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
Make sure you check these pages frequently, or sign up to our newsletter! To sign up for ESMO newsletters, create a myESMO account here and select the newsletters you’d like to receive.
Circulating tumour DNA analysis is a feasible tumour agnostic approach for evaluation of the efficacy of checkpoint blockade in patients at high risk of recurrence
Focusing on the KRAS G12C variant
Tislelizumab showed durable responses and was well tolerated in patients who received previous systemic treatment
New indication concerns adjuvant treatment of oesophageal or gastro-oesophageal junction cancer with residual disease following prior neoadjuvant chemoradiotherapy
Nutritional support also improved functional and QoL outcomes in a prospective, randomised, controlled EFFORT study
It is intended for the treatment of adult patiens with relapsed and refractory multiple myeloma
Genomic and histologic analyses of the KRYSTAL-1 study
SIOPEN data contribute to the rationale for future clinical trials introducing ALK targeted treatment in the frontline setting
The results of phase II study in Chinese patients with pulmonary sarcomatoid carcinomas and other non-small cell lung cancers harbouring MET exon 14 skipping alterations
The results form a prospective multicentre study provide a rationale for designing ctDNA-based risk-adaptive CAR T-cell clinical studies
EMA’s Pharmacovigilance Risk Assessment Committee concluded review of a safety signal
The results of the ECOG-ACRIN EA1131 study in basal subtype triple-negative breast cancer with residual disease after neoadjuvant chemotherapy
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.
